Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4874445
Max Phase: Preclinical
Molecular Formula: C55H77N19O11
Molecular Weight: 1180.34
Molecule Type: Unknown
Associated Items:
ID: ALA4874445
Max Phase: Preclinical
Molecular Formula: C55H77N19O11
Molecular Weight: 1180.34
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H]1NC(=O)CCC(=O)NCCCNC(=O)NC(=N)NCCC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
Standard InChI: InChI=1S/C55H77N19O11/c56-46(79)41(27-31-12-16-34(75)17-13-31)71-48(81)39(10-4-23-64-53(59)60)70-51(84)43(29-33-30-67-37-8-2-1-7-36(33)37)73-49(82)40-11-5-24-65-54(61)74-55(85)66-26-6-25-62-44(77)20-21-45(78)68-38(9-3-22-63-52(57)58)47(80)72-42(50(83)69-40)28-32-14-18-35(76)19-15-32/h1-2,7-8,12-19,30,38-43,67,75-76H,3-6,9-11,20-29H2,(H2,56,79)(H,62,77)(H,68,78)(H,69,83)(H,70,84)(H,71,81)(H,72,80)(H,73,82)(H4,57,58,63)(H4,59,60,64)(H4,61,65,66,74,85)/t38-,39-,40-,41-,42-,43-/m0/s1
Standard InChI Key: GAVPOEVMKIHXBX-KHVQSSSXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1180.34 | Molecular Weight (Monoisotopic): 1179.6050 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):